Access over 20 million homework & study documents

Docx (31)

Content type
User Generated
Rating
Showing Page:
1/5
Running head: PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS 1
Pharmacotherapy for Cardiovascular Disorders
Brooke Thompson
Walden University
September 8, 2019

Sign up to view the full document!

lock_open Sign Up
Showing Page:
2/5
PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS 2
Pharmacotherapy for Cardiovascular Disorders
Case Scenarrio
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA).
The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and
ischemic heart disease. Drugs currently prescribed include the following:
Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 13 tablets every 6 hours as needed for pain
This weeks assignment we are to evaluate the above scenario and chose a factor that may
influence the pharmacokinetic and pharmacodynamic processes. I have chosen to discuss
behavior and how it may impact the patients pharmacokinetic and pharmacodynamic processes.
The above scenario unfortunatley is a scenario we see far to often in todays array of patients. In
order to ne successful with the health goals and to achieve intended therapeutic goals a patient
must be able to be disciplined with themselves and scheduled. A patient that is overweight,
hypertension, a heart condition and also has a metabolic disorder such as diabetes are at a greater
risk for developing serious cardiovascular risks. Behaviors to engage in to decrease
cardiovascular risks are to maintain a healthy diet, reduce sodium intake, exercise regularly,

Sign up to view the full document!

lock_open Sign Up
Showing Page:
3/5

Sign up to view the full document!

lock_open Sign Up
End of Preview - Want to read all 5 pages?
Access Now
Unformatted Attachment Preview
Running head: PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS Pharmacotherapy for Cardiovascular Disorders Brooke Thompson Walden University September 8, 2019 1 PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS 2 Pharmacotherapy for Cardiovascular Disorders Case Scenarrio Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following: • Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun • Aspirin 81 mg daily • Metformin 1000 mg po bid • Glyburide 10 mg bid • Atenolol 100 mg po daily • Motrin 200 mg 1–3 tablets every 6 hours as needed for pain This weeks assignment we are to evaluate the above scenario and chose a factor that may influence the pharmacokinetic and pharmacodynamic processes. I have chosen to discuss behavior and how it may impact the patients pharmacokinetic and pharmacodynamic processes. The above scenario unfortunatley is a scenario we see far to often in todays array of patients. In order to ne successful with the health goals and to achieve intended therapeutic goals a patient must be able to be disciplined with themselves and scheduled. A patient that is overweight, hypertension, a heart condition and also has a metabolic disorder such as diabetes are at a greater risk for developing serious cardiovascular risks. Behaviors to engage in to decrease cardiovasc ...
Purchase document to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Anonymous
Very useful material for studying!

Studypool
4.7
Indeed
4.5
Sitejabber
4.4

Similar Documents